ArticleAnnals of translational medicine2021

Neoadjuvant sintilimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, single-center, phase 2 trial (ESONICT-1).

Zhenyang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.